18F-PM-PBB3
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 18F-PM-PBB3, covering 2020-03-12 to 2020-03-12. Get the full timeline:
Most recent: Clinical Trial Update: Alzheimer's Disease: Clinical Investigation and Neuroimage Studies Including 18F-PM-PBB3 and 18F-florbetapir (AV-45) PET Examination [Phase 2]